EICHOR
● Active Not Recruiting
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
Condition: Relapsed or Refractory B Cell Non-Hodgkin Lymphoma · Sponsor: Janssen Research & Development, LLC
About this study
The goal of this multicenter study is to test JNJ-90009530 in Relapsed or Refractory Non-Hodgkin Lymphoma Patients. The main questions the study aims to answer are: * can a dose of JNJ-90009530 be determined that is safe and well tolerated by patients. * will JNJ-90009530 help patients achieve a response and for how long?
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (15)
| University of Iowa Hospital | Iowa City, Iowa, United States | — |
| University of Kentucky | Lexington, Kentucky, United States | — |
| Mayo Clinic Rochester | Rochester, Minnesota, United States | — |
| Rutgers University | New Brunswick, New Jersey, United States | — |
| University Hospitals Cleveland Medical Center | Cleveland, Ohio, United States | — |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | — |
| MD Anderson Cancer Center | Houston, Texas, United States | — |
| Royal Prince Alfred Hospital | Camperdown, Australia | — |
| Monash Medical Centre | Clayton, Australia | — |
| Austin Hospital | Heidelberg, Australia | — |
| Royal Brisbane and Women's Hospital | Herston, Australia | — |
| Westmead Hospital | Westmead, Australia | — |
+ 3 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05784441